Current Opinion in Virology

Papers
(The H4-Index of Current Opinion in Virology is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Editorial Board196
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19148
Inhaled aerosol viral-vectored vaccines against tuberculosis98
Transmission patterns of hepatitis E virus94
Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?83
The enigmatic roles of Anelloviridae and Redondoviridae in humans71
Mutational escape from cellular immunity in viral hepatitis: variations on a theme70
Colonization of peripheral ganglia by herpes simplex virus type 1 and 266
Hepatitis-B virus: replication cycle, targets, and antiviral approaches60
Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy59
Editorial Board57
Human placental models for studying viral infections49
Editorial overview: Viral pathogenesis49
Virus–host protein interactions as footprints of human cytomegalovirus replication47
Viral–host interactions during splicing and nuclear export of influenza virus mRNAs46
Structural basis for neutralization of enterovirus45
Editorial Board44
The two faces of oligoadenylate synthetase-like: effective antiviral protein and negative regulator of innate immunity43
Hepatitis C virus envelope protein dynamics and the link to hypervariable region 142
Emerging technologies in the study of the virome41
Paramyxoviruses from bats: changes in receptor specificity and their role in host adaptation41
Recent progress in development of monoclonal antibodies against human cytomegalovirus41
New preventive strategies for respiratory syncytial virus infection in children38
The journey of herpesvirus capsids and genomes to the host cell nucleus36
Time to ‘Mind the Gap’ in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-235
A complex immune communication between eicosanoids and pulmonary macrophages33
Shopping for phages? Unpacking design rules for therapeutic phage cocktails33
Platelets in the pathogenesis of flavivirus disease32
Engineering therapeutic phages for enhanced antibacterial efficacy32
Mitigation of evolved bacterial resistance to phage therapy30
0.52640295028687